DoP-ASSOCHAM Conference on APIs:
Reducing Dependence on Imports

28 July, 2016, Hotel Best Western, Baddi, Himachal Pradesh

About the event  | Sponsorship Document | Registration Form  | Register Online

  Partner Knowledege Partner 
The Indian pharmaceutical industry ranks among the top five countries based on the production volume and accounts for about 8.5 per cent of global production and the turnover has increased from about US$ 0.3 billion in 1980 to about US$ 18 billion last year whereas, the estimated world market value of US$ 53 billion. Low cost of skilled manpower and innovation are some of the main factors supporting this growth. India is the third largest active pharmaceutical ingredient (API) market in the Asia-Pacific region and China is its main competitor.
The API industries in India include domestic and in-house consumption as well as exports. API manufacturers in India are trying to strengthen their marketing in regulated markets by different means viz., by focusing on the improvement of production yields; especially of critical products, through process modification, by increasing the productivity of high volume products through capacity re-balancing, by increasing sales in international market etc. Manufacturing standards in India are compliant with many international regulations. In addition, improvements in the technological capabilities of the country have enabled many manufacturers to venture into the highly regulated markets of the US and Europe.
One of the main technical challenges that we were facing during the execution of a technology transfer was to capture the relevant collective knowledge and experience at the sending units and to effectively transfer it to the receiving unit without loss of information. The know-how that is being passed over will form the basis for the manufacturing process, the in-process control strategy, process validation and ongoing continuous improvement. So, our ultimate goal is to create a platform to transfer the knowledge with sufficient level of detail to ensure that the results previously obtained at the sending unit will be reproduced in India in a robust manner. This can be achieved by compiling the existing process knowledge in detailed protocols and reports and providing India with detailed manufacturing instructions and process description. Elements such as material of construction of equipment and utensils, type of filters or stirrers and dimensions of equipment are examined. Care is also taken in evaluating that parameters like temperature and stirring ranges of the equipment are matching the process requirements.
The current growth in new medical technologies is spurring the demand for APIs worldwide today especially with the increased importation of raw pharmaceutical ingredients from emerging markets. Acknowledging the vast potential of the Pharmaceutical industry and its suffering at the hands of imported APIs.
With this background, Department of Pharmaceuticals, GoI in association with ASSOCHAM is organizing a seminar on “APIs : Reducing Dependence on Imports” on July 28, 2016 at Baddi, Himachal Pradesh as a forum for multilateral and face-to-face interaction for Pharma community members – research institutes, Pharma corporations, and financial & investing institutions, etc.
  •  To promote API industry nationally as well as locally, which in turn will help boost the Indian pharmaceutical industry further
  • To promote Pharmaceutical research and development within
  • To promote manufacturing of APIs in India, to help reduce the Indian pharmaceutical markets’ dependence on exports from other countries
  • To promote Public- Private Partnerships (PPP) model in development initiatives to address the key issues.
  • To provide incentives to attract investments.

Registration Fees: 

  • Rs. 1,000/- per delegate: 10% discount for more than three members from a company.